The 20 Best Cutaneous T-Cell Lymphoma (CTCL) Doctors in The United States

Christiane Querfeld is a Dermatologist practicing medicine in Duarte, California. Dr. Querfeld is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Thomas Kupper is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Kupper is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis. Dr. Kupper is board certified in Dermatology.

Joan Guitart is a Dermatologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 43 years. Dr. Guitart is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Lymphomatoid Papulosis. Dr. Guitart is board certified in American Board Of Dermatology - Dermatology (Certified).

Alain Rook is a Dermatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Rook is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome. Dr. Rook is board certified in Dermatology, 1991, Nephrology, 1980, and Internal Medicine, 1979. Dr. Rook is currently accepting new patients.

Pamela Allen is an Anesthesiologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 5 years. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Anesthesiology, 2025.

Dr. Jennifer DeSimone is a specialty care physician board certified in dermatology. She joined Inova Medical Group with 5 years of clinical experience. She has a special interest in management of cutaneous lymphomas, skin cancer in organ transplant recipients and other complex skin cancers. Most recently Dr. DeSimone served as a Director of Cutaneous Lymphoma. Dr. DeSimone became interested in lymphomas of the skin because of the rarity of the disease and the need for greater understanding of its origin and development of more effective therapy. Her goal is to help educate her patients about skin cancer etiology, management and importantly, prevention. A native of Northern Virginia, Dr. DeSimone currently resides in Fairfax County with her husband and two children. In her spare time she enjoys cooking, entertaining, and trail running. Dr. Desimone is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Lymphomatoid Papulosis.

Nicole Leboeuf is a Dermatologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Leboeuf is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis. Dr. Leboeuf is board certified in Dermatology.

Dr. Sima Rozati is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. She specializes in medical dermatology, cutaneous lymphoma, and supportive oncodermatology. She received her medical degree from the Shahid Beheshti University of Medical Sciences in Tehran. After completing her internal medicine residency at the Cleveland Clinic, she completed a research fellowship and PhD in cutaneous lymphoma at the University Hospital of Zürich in Switzerland. She returned to the U.S. where she completed cutaneous lymphoma fellowship, under the mentorship of Dr. Youn Kim, followed by dermatology residency at Stanford University School of Medicine in California. In a multidisciplinary environment, Dr. Rozati aims to provide excellent care to patients with cutaneous lymphoma and cancer whom are experiencing cutaneous adverse events from targeted therapies, immune- and chemotherapies. Dr. Rozati’s research interest focuses on cutaneous lymphoma, understanding the biology of this heterogeneous group of malignancies by analyzing the mutational and epigenetic landscape. Her translational research efforts is directed to investigate novel targeted and immunotherapeutic for cutaneous T cell lymphoma. She is a member of different professional organizations, including the American Academy of Dermatology and Woman’s dermatologic Society. Dr. Rozati is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Rozati is board certified in American Board Of Dermatology.

I have two areas of clinical expertise: cutaneous lymphoma and hair disorders. In the area of cutaneous lymphoma, I have focused my research on clinical trials for new treatments and consensus building to establish standard guidelines for staging, evaluation, and treatment of patients, as well as the methodology used in clinical trials. My patients are invited to participate in my ongoing database, which captures their response to treatments. My goal is to find a cure for these cancers or, barring that, long lasting remissions. In the area of hair disorders, my goal is to help referring physicians diagnose and treat effectively multiple types of hair loss. My consultative practice is now focused on scarring alopecias, including frontal fibrosing alopecia and hair loss in African-American women in which causes are not obvious. My research focuses on collaborative work with multiple centers in the United States to help create knowledge and new treatments. Dr. Olsen is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Olsen is board certified in American Board Of Dermatology, Dermatology.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Cecilia Larocca is a Dermatologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Larocca is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, Eosinophilic Fasciitis, and Tissue Biopsy. Dr. Larocca is board certified in Dermatology.

Michael Girardi is a Dermatologist practicing medicine in New Haven, Connecticut. Dr. Girardi is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Patricia Myskowski is a Dermatologist practicing medicine in New York, New York. Dr. Myskowski is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), and Lymphomatoid Papulosis.

Shamir Geller is a Dermatologist practicing medicine in New York, New York. Dr. Geller is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Lucia Seminario is a Dermatologist practicing medicine in Tampa, Florida. Dr. Seminario is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, Pyoderma Gangrenosum, and Bone Marrow Aspiration.

Auris Huen is a Dermatologist practicing medicine in Cary, North Carolina. Dr. Huen is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Lymphomatoid Papulosis, and Thymectomy.

Michi Shinohara is a Dermatologist practicing medicine in Seattle, Washington. Dr. Shinohara is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Jaehyuk Choi is a Dermatologist practicing medicine in Chicago, Illinois. Dr. Choi is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Sezary Syndrome, Mycosis Fungoides, T-Cell Lymphoma, and Liver Embolization.

Larisa Geskin is a Hematologist and a Dermatologist practicing medicine in New York, New York. Dr. Geskin is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.